INSTITUTO DE BIOMEDICINA Y GENÉTICA MOLECULAR (IBGM)
Instituto
Instituto de Parasitología y Biomedicina López Neyra
Armilla, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Parasitología y Biomedicina López Neyra (13)
2023
2021
-
Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477
2019
-
VE-cadherin promotes vasculogenic mimicry by modulating kaiso-dependent gene expression
Cell Death and Differentiation, Vol. 26, Núm. 2, pp. 348-361
2016
-
Autophagy requires poly(adp-ribosyl)ation-dependent AMPK nuclear export
Cell Death and Differentiation, Vol. 23, Núm. 12, pp. 2007-2018
2015
-
Deciphering the Insights of Poly(ADP-Ribosylation) in Tumor Progression
Medicinal Research Reviews, Vol. 35, Núm. 4, pp. 678-697
-
Dioxin receptor regulates aldehyde dehydrogenase to block melanoma tumorigenesis and metastasis
Molecular Cancer, Vol. 14, Núm. 1
-
PARP targeting counteracts gliomagenesis through induction of mitotic catastrophe and aggravation of deficiency in homologous recombination in PTEN-mutant glioma
Oncotarget, Vol. 6, Núm. 7, pp. 4790-4803
2013
-
PARP-1 Regulates Metastatic Melanoma through Modulation of Vimentin-induced Malignant Transformation
PLoS Genetics, Vol. 9, Núm. 6
2012
-
ROS-induced DNA damage and PARP-1 are required for optimal induction of starvation-induced autophagy
Cell Research, Vol. 22, Núm. 7, pp. 1181-1198
2011
-
Poly(ADP-ribose)-dependent regulation of Snail1 protein stability
Oncogene, Vol. 30, Núm. 42, pp. 4365-4372
2009
-
PARP inhibitors: New partners in the therapy of cancer and inflammatory diseases
Free Radical Biology and Medicine, Vol. 47, Núm. 1, pp. 13-26
2008
-
Poly(ADP-ribose)polymerase-1 (PARP-1) in carcinogenesis: Potential role of PARP inhibitors in cancer treatment
Clinical and Translational Oncology, Vol. 10, Núm. 6, pp. 318-323